FI972821A0 - Geneettisesti ohjatun solukuoleman geenit ja proteiinit - Google Patents

Geneettisesti ohjatun solukuoleman geenit ja proteiinit

Info

Publication number
FI972821A0
FI972821A0 FI972821A FI972821A FI972821A0 FI 972821 A0 FI972821 A0 FI 972821A0 FI 972821 A FI972821 A FI 972821A FI 972821 A FI972821 A FI 972821A FI 972821 A0 FI972821 A0 FI 972821A0
Authority
FI
Finland
Prior art keywords
genes
proteins
cell death
controlled cell
genetically controlled
Prior art date
Application number
FI972821A
Other languages
English (en)
Swedish (sv)
Other versions
FI972821A (fi
Inventor
Junying Yuan
Masayuki Miura
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Publication of FI972821A0 publication Critical patent/FI972821A0/fi
Publication of FI972821A publication Critical patent/FI972821A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F02—COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
    • F02B—INTERNAL-COMBUSTION PISTON ENGINES; COMBUSTION ENGINES IN GENERAL
    • F02B75/00—Other engines
    • F02B75/02—Engines characterised by their cycles, e.g. six-stroke
    • F02B2075/022—Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle
    • F02B2075/027—Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle four

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI972821A 1995-01-04 1997-06-30 Geneettisesti ohjatun solukuoleman geenit ja proteiinit FI972821A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/368,704 US6087160A (en) 1993-06-24 1995-01-04 Programmed cell death genes and proteins
PCT/US1996/000177 WO1996020721A1 (en) 1995-01-04 1996-01-04 Programmed cell death genes and proteins

Publications (2)

Publication Number Publication Date
FI972821A0 true FI972821A0 (fi) 1997-06-30
FI972821A FI972821A (fi) 1997-09-03

Family

ID=23452396

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972821A FI972821A (fi) 1995-01-04 1997-06-30 Geneettisesti ohjatun solukuoleman geenit ja proteiinit

Country Status (10)

Country Link
US (2) US6087160A (fi)
EP (1) EP0808169A4 (fi)
JP (1) JPH11500304A (fi)
AU (1) AU4747296A (fi)
CA (1) CA2209526A1 (fi)
FI (1) FI972821A (fi)
IL (1) IL116671A0 (fi)
MX (1) MX9705039A (fi)
NO (1) NO973107L (fi)
WO (1) WO1996020721A1 (fi)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993025685A1 (en) * 1992-06-12 1993-12-23 Massachusetts Institute Of Technology Cloning and characterization of the cell death genes ced-3 and ced-4
US6015665A (en) * 1995-02-13 2000-01-18 The Regents Of The University Of Michigan Method and composition for regulating apoptosis
US7097972B1 (en) 1995-02-13 2006-08-29 Regents Of The University Of Michigan Method and composition for regulating apoptosis
US6060238A (en) * 1995-02-13 2000-05-09 The Regents Of The University Of Michigan Method and composition for regulating apoptosis
US6747138B1 (en) 1995-04-03 2004-06-08 Regents Of The University Of Michigan Methods and compositions for regulating Fas-associated apoptosis
US7807783B1 (en) 1995-04-03 2010-10-05 The Regents Of The University Of Michigan Methods and compositions for regulating FAS-associated apoptosis
US6214572B1 (en) * 1996-08-09 2001-04-10 The General Hospital Corporation Programmed cell death and ICH-3
US5897992A (en) 1996-09-27 1999-04-27 Cold Spring Harbor Laboratory Cell-free assay using oncogene-induced apoptosis in drug-resistant cells
US6342611B1 (en) 1997-10-10 2002-01-29 Cytovia, Inc. Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for capsases and other enzymes and the use thereof
US6184210B1 (en) 1997-10-10 2001-02-06 Cytovia, Inc. Dipeptide apoptosis inhibitors and the use thereof
CN1297354A (zh) * 1998-03-16 2001-05-30 西托维亚公司 二肽卡斯帕酶抑制剂及其用途
WO1999052925A1 (en) * 1998-04-16 1999-10-21 The General Hospital Corporation Programmed cell death and caspase-12
WO2000004914A1 (en) 1998-07-21 2000-02-03 Cytovia, Inc. Novel fluorescence dyes and their applications for whole cell fluorescence screening assays for caspases, peptidases, proteases and other enzymes and the use thereof
ATE336480T1 (de) 1999-03-16 2006-09-15 Cytovia Inc Substituierte 2-aminobenzamin caspase inhibitoren und ihre verwendung
BR0009610A (pt) 1999-04-09 2002-02-13 Cytovia Inc Inibidores de caspase e uso dos mesmos
US6462041B1 (en) 1999-05-21 2002-10-08 Cytovia, Inc. Gambogic acid, analogs and derivatives as activators of caspases and inducers of apoptosis
CA2383002A1 (en) 1999-08-27 2001-03-08 Cytovia, Inc. Substituted .alpha.-hydroxy acid caspase inhibitors and the use thereof
US6566338B1 (en) 1999-10-12 2003-05-20 Cytovia, Inc. Caspase inhibitors for the treatment and prevention of chemotherapy and radiation therapy induced cell death
AU781986B2 (en) 1999-11-05 2005-06-23 Cytovia, Inc. Substituted 4H-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof
JP2003520854A (ja) 2000-01-27 2003-07-08 サイトビア インコーポレイテッド カスパーゼのアクチベーターおよびアポトーシスのインデューサーとしての置換ニコチンアミドおよび類似物およびそれらの使用
CA2406271A1 (en) 2000-04-18 2001-10-25 Cytovia, Inc. Substituted 1,4-thiazepine and analogs and their use as activators of caspases
US7569351B2 (en) * 2000-08-03 2009-08-04 Oncotherapy Science, Inc. P53 dependent apoptosis-associated gene and protein
AU2001278135A1 (en) 2000-08-03 2002-02-18 Cytovia, Inc. Method of identifying immunosuppressive agents
WO2002024720A1 (en) * 2000-09-20 2002-03-28 Isis Pharmaceuticals, Inc. Antisense modulation of caspase 2 expression
US6716851B2 (en) 2000-12-12 2004-04-06 Cytovia, Inc. Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators or caspases and inducers of apoptosis and the use thereof
WO2002092594A1 (en) 2001-05-16 2002-11-21 Cytovia, Inc. Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
WO2002098420A1 (en) * 2001-06-01 2002-12-12 Cytovia, Inc. 4-substituted-1-(arylmethylidene)thiosemicarbazide, 4-substituted-1-(arylcarbonyl)thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereof
CN1638776A (zh) 2001-06-08 2005-07-13 西托维亚公司 取代的3－芳基－5－芳基－[1,2,4]－噁二唑和类似物
AU2003230411A1 (en) 2002-05-16 2003-12-02 Cytovia, Inc. Substituted 4-aryl-4h-pyrrolo(2,3-h)chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
AU2003241482A1 (en) 2002-05-16 2003-12-02 Cytovia, Inc. Substituted 4h-chromenes, 2h-chromenes, chromans and analogs as activators of caspases and inducers of apoptosis and the use thereof
US7144876B2 (en) 2002-12-18 2006-12-05 Cytovia, Inc. 3,5-Disubstituted-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
US7618975B2 (en) 2003-07-03 2009-11-17 Myriad Pharmaceuticals, Inc. 4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis and the use thereof
CN1954882A (zh) * 2005-10-14 2007-05-02 李海 长效人重组可溶性肿瘤坏死因子α受体在制备防治肝衰竭药物中的用途
EP3191508B1 (en) 2014-09-09 2020-11-04 Boehringer Ingelheim Animal Health USA Inc. Mammalian cell lines expressing functional nematode acetylcholine receptors and use thereof for high-throughput screening assays

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991015577A1 (en) * 1990-04-04 1991-10-17 Black, Roy, A. INTERLEUKIN 1'beta' PROTEASE
EP0533350B1 (en) * 1991-08-16 1999-05-26 Merck & Co. Inc. DNA encoding precursor interleukin 1B converting enzyme
EP0600880B1 (en) * 1991-08-30 2004-01-07 Vertex Pharmaceuticals Incorporated Interleukin 1- beta protease and interleukin 1-beta protease inhibitors
GB9124986D0 (en) * 1991-11-25 1992-01-22 Greenberg Arnold H Natural killer cell granule protein
WO1993025685A1 (en) * 1992-06-12 1993-12-23 Massachusetts Institute Of Technology Cloning and characterization of the cell death genes ced-3 and ced-4
WO1993025694A1 (en) * 1992-06-12 1993-12-23 Massachusetts Institute Of Technology Inhibitors of ced-3 and related proteins
WO1995000160A1 (en) * 1993-06-24 1995-01-05 The General Hospital Corporation Programmed cell death genes and proteins
AU7250494A (en) * 1994-06-23 1996-01-19 Human Genome Sciences, Inc. Interleukin-1 beta converting enzyme like apoptosis protease-1 and 2

Also Published As

Publication number Publication date
WO1996020721A1 (en) 1996-07-11
NO973107D0 (no) 1997-07-03
AU4747296A (en) 1996-07-24
US6087160A (en) 2000-07-11
CA2209526A1 (en) 1996-07-11
FI972821A (fi) 1997-09-03
JPH11500304A (ja) 1999-01-12
IL116671A0 (en) 1996-05-14
US20030124105A1 (en) 2003-07-03
NO973107L (no) 1997-08-26
EP0808169A4 (en) 2002-09-11
EP0808169A1 (en) 1997-11-26
MX9705039A (es) 1997-10-31

Similar Documents

Publication Publication Date Title
FI972821A0 (fi) Geneettisesti ohjatun solukuoleman geenit ja proteiinit
EP0711174A4 (en) REGULATORY GENES OF PROGRAMMED CELL DEATH AND PROTEINS
NZ263025A (en) Development genes and proteins from plants homologous to mammalian qm genes and their use
FI942935A0 (fi) Peptidien nukleiinihappoja ja niiden vaikutus geneettiseen materiaaliin
NO943344D0 (no) MN-gen og -protein
DE69433168D1 (de) In vitro vermehrung von stammzellen
EE9900357A (et) Geenisekvenaator ja meetodid
EP0852627A4 (en) CELL DEATH PROTEIN
AU6687696A (en) Transgenic swine and swine cells having human hla genes
DE69322573D1 (de) Zellkultureinsatz
FI980033A (fi) Solujen kiinnittymisen inhibiittoreita
DE69319983D1 (de) Zellkultureinsatz
DK299087D0 (da) Proteins and derivatives thereof
DE69329087D1 (de) Bestimmung von Batterietemperatur und -typ
AU6254494A (en) Polyelectrolyte dna conjugation and genetic transformation of an animal
NO964758D0 (no) Anvendelse av von Willebrand-faktor og farmasöytiske preparater
GB9516059D0 (en) Novel genes and proteins
NO982100D0 (no) Peptid-derivater av Dolastatin 15 og deres anvendelse
DK61486D0 (da) Gener for biologisk aktive proteiner
AU4778193A (en) Inhibition of retroviral expression by interferon-induced cellular genes and proteins
DE69301018D1 (de) Menschliches Glycosyltransferase Gen
DE69523956D1 (de) Vermehrung von knochenmarksstützzellen
DE59509748D1 (de) Radikalisch polymerisierbare Zubereitungen und ihre Verwendung
KR940009040U (ko) 자연분봉이 가능한 토종벌통
KR970006484A (ko) 수두 바이러스의 당단백질을 대량발현시키는 동물세포주